326 filings
6-K
CLLS
Cellectis
6 May 24
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
6:00am
6-K
CLLS
Cellectis
2 May 24
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
8:03pm
6-K
CLLS
Cellectis
22 Apr 24
Cellectis Presents Novel TALENĀ® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
4:35pm
6-K
CLLS
Cellectis
10 Apr 24
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
4:35pm
6-K
CLLS
Cellectis
8 Apr 24
Current report (foreign)
4:35pm
6-K
ysyo v41g5
16 Jan 24
Current report (foreign)
4:45pm
6-K
c77p mlwustv
22 Dec 23
Current report (foreign)
4:35pm
6-K
tpr ecs5i047e0iiw3k
22 Dec 23
Current report (foreign)
4:01pm
6-K
94zlod07pp8 rkp
5 Dec 23
Current report (foreign)
4:01pm
6-K
m15n7 a3ku
17 Nov 23
Current report (foreign)
4:56pm
6-K
ldyekrt8bzh
17 Nov 23
Current report (foreign)
4:35pm
6-K
nsac5
15 Nov 23
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
7:48am
6-K
vvss5qlj
9 Nov 23
Joint Researchand Collaboration Agreement
4:01pm
6-K
pfwhbnlrsmlr n0apfxt
6 Nov 23
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
4:35pm
6-K
w0z18vpv3lz1p373ys4w
6 Nov 23
Current report (foreign)
4:30pm
6-K
5pnjab 5m4
2 Nov 23
Current report (foreign)
4:35pm
6-K
ezvb019rpcq1
1 Nov 23
Current report (foreign)
4:35pm
6-K
k30ohixi354plh2hk0jq
1 Nov 23
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
6:44am
6-K
adtgmjpsosf cf
31 Oct 23
Current report (foreign)
5:09pm
6-K
oyt9ax22 s1z
31 Oct 23
Current report (foreign)
4:35pm